Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Oct 13;9(3):194-205.
doi: 10.1159/000480721. eCollection 2017 Sep-Dec.

Diffuse Dermal Angiomatosis of the Breast: A Distinct Entity in the Spectrum of Cutaneous Reactive Angiomatoses - Clinicopathologic Study of Two Cases and Comprehensive Review of the Literature

Affiliations
Case Reports

Diffuse Dermal Angiomatosis of the Breast: A Distinct Entity in the Spectrum of Cutaneous Reactive Angiomatoses - Clinicopathologic Study of Two Cases and Comprehensive Review of the Literature

Jörg Galambos et al. Case Rep Dermatol. .

Abstract

Diffuse dermal angiomatosis (DDA) is a rare reactive angioproliferation in the skin and considered to be a subtype in the group of cutaneous reactive angiomatoses. DDA is clinically characterized by livedoid patches and plaques with tender ulceration. Its histologic features are a reactive diffuse proliferation of bland endothelial cells and pericytes within the dermis, forming small capillary vessels. Previously described cases of DDA most commonly involved the limbs and were associated with a wide spectrum of predisposing comorbidities, especially advanced atherosclerotic vascular disease and arteriovenous fistula. However, several cases of DDA of the breast (DDAB) have been reported in recent years. In this study we present 2 additional patients with DDAB and review all 36 cases of DDAB published in the literature. We describe the clinical and histopathologic characteristics, hypothesized pathogenetic mechanisms, and predisposing conditions of this rare skin disorder and discuss treatment options. The breast is a more commonly involved site of DDA than previously believed. DDAB typically occurs in middle-aged women and is associated with macromastia, overweight or obesity, and probably smoking. Predisposing comorbid conditions differ from those of DDA involving other parts of the body, making DDAB a unique clinicopathologic entity in the spectrum of cutaneous reactive angiomatoses. Currently there is no consensus on the best therapeutic approach. Isotretinoin and other medical therapies have been used with limited success. Breast reduction surgery appears to be a viable treatment option for DDAB in women with macromastia and might provide definitive healing.

Keywords: Cutaneous reactive angiomatosis; Diffuse dermal angiomatosis; Diffuse dermal angiomatosis of the breast; Reactive angioendotheliomatosis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Diffuse dermal angiomatosis of the breast. a Reticulated erythematous to violaceous patches involving both breasts, with ulceration on the right side. b Detail with prominent vessels surrounding the lesion. c Follow-up 4.5 months after bilateral reduction mammaplasty with no recurrence of the condition.
Fig. 2.
Fig. 2.
Histology of diffuse dermal angiomatosis. a Diffuse proliferation of capillary vessels in the superficial and deep dermis between the collagen bundles, with characteristic shallow ulceration. b Strong expression of CD31 highlighting the endothelial nature of proliferating cells. a Hematoxylin-eosin stain. Original magnification: a, b ×40.
Fig. 3.
Fig. 3.
a Dense proliferation of endothelial cells without nuclear atypia, forming capillary vessels with barely identifiable vascular lumina, surrounding a normal vessel. b Nuclear expression of ERG, a highly specific marker for vascular endothelium. c Newly formed capillary vessels show a normal anatomic architecture of blood vessels with an outer layer of α-SMA-positive pericytes. a Hematoxylin-eosin stain. Original magnification: a–c ×200.

Similar articles

Cited by

References

    1. Krell JM, Sanchez RL, Solomon AR. Diffuse dermal angiomatosis: a variant of reactive cutaneous angioendotheliomatosis. J Cutan Pathol. 1994;21:363–370. - PubMed
    1. McLaughlin ER, Morris R, Weiss SW, Arbiser JL. Diffuse dermal angiomatosis of the breast: response to isotretinoin. J Am Acad Dermatol. 2001;45:462–465. - PubMed
    1. Reusche R, Winocour S, Degnim A, Lemaine V. Diffuse dermal angiomatosis of the breast: a series of 22 cases from a single institution. Gland Surg. 2015;4:554–560. - PMC - PubMed
    1. Rongioletti F, Rebora A. Cutaneous reactive angiomatoses: patterns and classification of reactive vascular proliferation. J Am Acad Dermatol. 2003;49:887–896. - PubMed
    1. Requena L, El-Shabrawi-Caelen L, Walsh SN, Segura S, Ziemer M, Hurt MA, Sangüeza OP, Kutzner H. Intralymphatic histiocytosis. A clinicopathologic study of 16 cases. Am J Dermatopathol. 2009;31:140–151. - PubMed

Publication types

LinkOut - more resources